Sacubitril/valsartan in PARADIGM-HF

Nicolas Vodovar¹, Hélène Nougué², Jean-Marie Launay³, Alain Cohen Solal⁴, Damien Logeart⁴

Affiliations

¹ Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche S 942, Paris, France. Electronic address: nicolas.vodovar@inserm.fr.
² Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche S 942, Paris, France; Department of Anaesthesiology and Intensive Care, Lariboisière Hospital, Paris, France.
³ Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche S 942, Paris, France; Centre for Biological Resources BB-0033-00064, Lariboisière Hospital, Paris, France.
⁴ Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche S 942, Paris, France; Department of Cardiology, Lariboisière Hospital, Paris, France; Université Paris Diderot-Sorbonne Paris Cité, Paris, France.

PMID: 28645438
DOI: 10.1016/S2213-8587(17)30177-8

Comment

Sacubitril/valsartan in PARADIGM-HF

Nicolas Vodovar et al. Lancet Diabetes Endocrinol. 2017 Jul.

. 2017 Jul;5(7):495-496.

doi: 10.1016/S2213-8587(17)30177-8.

Authors

Nicolas Vodovar¹, Hélène Nougué², Jean-Marie Launay³, Alain Cohen Solal⁴, Damien Logeart⁴

Affiliations

¹ Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche S 942, Paris, France. Electronic address: nicolas.vodovar@inserm.fr.
² Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche S 942, Paris, France; Department of Anaesthesiology and Intensive Care, Lariboisière Hospital, Paris, France.
³ Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche S 942, Paris, France; Centre for Biological Resources BB-0033-00064, Lariboisière Hospital, Paris, France.
⁴ Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche S 942, Paris, France; Department of Cardiology, Lariboisière Hospital, Paris, France; Université Paris Diderot-Sorbonne Paris Cité, Paris, France.

PMID: 28645438
DOI: 10.1016/S2213-8587(17)30177-8

Erratum in

Correction to Lancet Diabetes Endocrinol 2017; 5: 495-96.
[No authors listed] [No authors listed] Lancet Diabetes Endocrinol. 2019 Jul;7(7):e19. doi: 10.1016/S2213-8587(19)30201-3. Lancet Diabetes Endocrinol. 2019. PMID: 31227251 No abstract available.

Expression of concern in

Expression of concern: Correspondence by Nicolas Vodovar et al on sacubitril/valsartan in PARADIGM-HF.
The Editors Of The Lancet Diabetes Endocrinology. The Editors Of The Lancet Diabetes Endocrinology. Lancet Diabetes Endocrinol. 2019 Apr;7(4):250-251. doi: 10.1016/S2213-8587(19)30062-2. Epub 2019 Feb 21. Lancet Diabetes Endocrinol. 2019. PMID: 30797751 No abstract available.

No abstract available

PubMed Disclaimer

Comment in

Sacubitril/valsartan in PARADIGM-HF - Authors' reply.
Seferovic JP, Claggett B, Solomon SD; PARADIGM-HF investigators. Seferovic JP, et al. Lancet Diabetes Endocrinol. 2017 Jul;5(7):496. doi: 10.1016/S2213-8587(17)30179-1. Lancet Diabetes Endocrinol. 2017. PMID: 28645439 No abstract available.

Comment on

Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial.
Seferovic JP, Claggett B, Seidelmann SB, Seely EW, Packer M, Zile MR, Rouleau JL, Swedberg K, Lefkowitz M, Shi VC, Desai AS, McMurray JJV, Solomon SD. Seferovic JP, et al. Lancet Diabetes Endocrinol. 2017 May;5(5):333-340. doi: 10.1016/S2213-8587(17)30087-6. Epub 2017 Mar 18. Lancet Diabetes Endocrinol. 2017. PMID: 28330649 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Sacubitril/valsartan in PARADIGM-HF

Affiliations

Sacubitril/valsartan in PARADIGM-HF

Authors

Affiliations

Erratum in

Expression of concern in

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Research Materials

Miscellaneous